23.10.2023
Cerenion awarded third patent on its C-TREND® technology in China
The National Intellectual Property Administration of the P.R.C. (CNIPA) has awarded Cerenion its third patent on C-Trend® technology in China. For the C-Trend EEG analysis software, this patent is the eleventh globally.
The patent gives a strong protection to the C-Trend Index algorithm, a core component of Cerenion's C-Trend technology. This algorithm processes EEG signals, transforming them into a single numerical value, the C-Trend Index. This index provides a concise measure of a patient's EEG slow wave activity, a fundamental aspect of a healthy brain, typically observed during periods of sedation and deep sleep.
Cerenion's C-Trend technology has successfully secured several patents in the United States, the European Union, Japan, and China, and multiple applications for intellectual property rights have been initiated on a global scale.
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Not available in the United States. Cerenion™, Cerenion C-Trend™, C-Trend™, "The next-generation brain monitoring company"™ and "The pulse of the brain"™ are registered trademarks and/or trademarks of Cerenion Oy. Cerenion C-Trend™ is intended for use by qualified medical practitioners who will exercise professional judgment in its use. Cerenion technology is protected by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2020.